X0306 4 2021-06-29 0 0001783032 Elevation Oncology, Inc. ELEV 0001765710 Qiming U.S. Healthcare Fund II, L.P. 11100 NE 8TH ST SUITE 200 BELLEVUE WA 98004 0 0 1 0 0001868862 Qiming U.S. Healthcare GP II, LLC 11100 NE 8TH ST SUITE 200 BELLEVUE WA 98004 0 0 1 0 Common Stock 2021-06-29 4 C 0 1656577 0.00 A 1656577 D Common Stock 2021-06-29 4 C 0 401065 0.00 A 2057642 D Common Stock 2021-06-29 4 P 0 312500 16.00 A 2370142 D Series A Preferred Stock 2021-06-29 4 C 0 7000000 0.00 D Common Stock 1656577 0 D Series B Preferred Stock 2021-06-29 4 C 0 1694730 0.00 D Common Stock 401065 0 D The Shares of the Issuer's Preferred Stock automatically converted on a 4.225582-for-one basis into the number of shares of the Issuer's Common Stock in shown in column 7 immediately upon the closing of the Issuer's initial public offering, and had no expiration date. The securities are directly held by Qiming U.S. Healthcare Fund II, L.P. ("Qiming"). Qiming U.S. Healthcare GP II, LLC ("Qiming GP") is the General Partner of Qiming, and may deem beneficial ownership of shares held by Qiming, and includes Gary Rieschel, as Managing Member of Qiming GP, and Mark McDade, Co-Founder, and Partner of Qiming, that each may share voting and investment power of the shares held by Qiming. Qiming U.S. Healthcare Fund II, L.P., by Qiming U.S. Healthcare GP II, LLC, its General Partner 2021-07-01